Jilin Province Huinan Changlong Bio-pharmacy Co Ltd banner
J

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049

Watchlist Manager
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049
Watchlist
Price: 2.41 HKD 0.84% Market Closed
Market Cap: HK$1.4B

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
J
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049
Research & Development
-¥44.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Research & Development
-¥3.4B
CAGR 3-Years
-26%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Research & Development
-¥6.7B
CAGR 3-Years
-13%
CAGR 5-Years
-7%
CAGR 10-Years
-22%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Research & Development
-¥323.2m
CAGR 3-Years
-5%
CAGR 5-Years
-13%
CAGR 10-Years
-12%
Zhejiang Nhu Co Ltd
SZSE:002001
Research & Development
-¥1.1B
CAGR 3-Years
-8%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Research & Development
-¥1.4B
CAGR 3-Years
-77%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
No Stocks Found

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
Glance View

Market Cap
1.4B HKD
Industry
Pharmaceuticals

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. engages in the manufacture and distribution of Chinese medicines and pharmaceutical products. The company is headquartered in Tonghua, Jilin. The company went IPO on 2001-05-24. Its products are mainly sold under the brand names of Changlong and Qing Tong. Its primary products include tablets, capsules, bulk drug, membrane, pills, bulk drug, powder for injection, lyophilized powder for injection, small volume parenteral solutions, sterile bulk drug and solution. The firm is also engaged in the trading of biochemical medicine through its subsidiaries. Its principal subsidiaries include Jilin Province Huinan Changlong Pharmacy Trading Company Limited and Jilin Province Medicinal Plants Trading Company Limited.

Intrinsic Value
5.65 HKD
Undervaluation 57%
Intrinsic Value
Price HK$2.41
J

See Also

What is Jilin Province Huinan Changlong Bio-pharmacy Co Ltd's Research & Development?
Research & Development
-44.4m CNY

Based on the financial report for Dec 31, 2024, Jilin Province Huinan Changlong Bio-pharmacy Co Ltd's Research & Development amounts to -44.4m CNY.

What is Jilin Province Huinan Changlong Bio-pharmacy Co Ltd's Research & Development growth rate?
Research & Development CAGR 1Y
-239%

Over the last year, the Research & Development growth was -239%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett